Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms.

Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R.

World J Gastroenterol. 2017 Feb 21;23(7):1241-1249. doi: 10.3748/wjg.v23.i7.1241.

2.

Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland.

Wyskida K, Żak-Gołąb A, Wajda J, Klein D, Witkowicz J, Ficek R, Rotkegel S, Spiechowicz U, Kocemba Dyczek J, Ciepał J, Olszanecka-Glinianowicz M, Więcek A, Chudek J.

Int Urol Nephrol. 2016 May;48(5):765-71. doi: 10.1007/s11255-016-1255-6. Epub 2016 Mar 21.

3.

Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.

Gluba-Brzózka A, Michalska-Kasiczak M, Franczyk B, Nocuń M, Toth P, Banach M, Rysz J.

Lipids Health Dis. 2016 Feb 3;15:22. doi: 10.1186/s12944-016-0191-x. Erratum in: Lipids Health Dis. 2016;15(1):62.

4.

Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.

Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, Pottel H, Cavalier E.

BMC Nephrol. 2014 Sep 4;15:145. doi: 10.1186/1471-2369-15-145.

5.

Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease.

Nemcsik J, Kiss I, Tislér A.

World J Nephrol. 2012 Feb 6;1(1):25-34. doi: 10.5527/wjn.v1.i1.25. Review.

6.

Vascular and valvular calcification in chronic peritoneal dialysis patients.

Wang AY.

Int J Nephrol. 2011;2011:198045. doi: 10.4061/2011/198045. Epub 2011 Aug 2.

7.

Calcific uremic arteriolopathy in peritoneal dialysis populations.

New N, Mohandas J, John GT, Ratanjee S, Healy H, Francis L, Ranganathan D.

Int J Nephrol. 2011;2011:982854. doi: 10.4061/2011/982854. Epub 2011 Jun 27.

8.

Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.

Schlieper G, Westenfeld R, Krüger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, Djuric Z, Damjanovic T, Ketteler M, Vermeer C, Dimkovic N, Floege J, Schurgers LJ.

J Am Soc Nephrol. 2011 Feb;22(2):387-95. doi: 10.1681/ASN.2010040339.

9.

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH.

Ann Intern Med. 2010 May 18;152(10):640-8. doi: 10.7326/0003-4819-152-10-201005180-00004.

10.

The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.

Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZA.

Clin J Am Soc Nephrol. 2010 Apr;5(4):568-75. doi: 10.2215/CJN.07081009. Epub 2010 Feb 4.

11.

The association of uncarboxylated matrix Gla protein with mitral annular calcification differs by diabetes status: The Heart and Soul study.

Parker BD, Schurgers LJ, Vermeer C, Schiller NB, Whooley MA, Ix JH.

Atherosclerosis. 2010 May;210(1):320-5. doi: 10.1016/j.atherosclerosis.2009.11.023. Epub 2009 Nov 22.

12.

Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study.

Parker BD, Ix JH, Cranenburg EC, Vermeer C, Whooley MA, Schurgers LJ.

Nephrol Dial Transplant. 2009 Jul;24(7):2095-101. doi: 10.1093/ndt/gfp024. Epub 2009 Feb 9.

13.

Vitamin K-dependent proteins, warfarin, and vascular calcification.

Danziger J.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1504-10. doi: 10.2215/CJN.00770208. Epub 2008 May 21. Review.

Supplemental Content

Support Center